Dr. Spencer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
31157 Woodward Ave
Royal Oak, MI 48073Phone+1 248-336-0123Fax+1 248-336-3190
Education & Training
Cleveland Clinic FoundationResidency, Urology, 1983 - 1988
University of Michigan Medical SchoolClass of 1983
Certifications & Licensure
FL State Medical License 1988 - Present
MI State Medical License 1990 - 2027
OH State Medical License 1986 - 1990- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification meridianEMR, meridianEMR, Inc., 2012
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 49 citationsA prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy.Barbara A. Pockaj, James Chih-Hsin Yang, Michael T. Lotze, J. R. Lange, William F. Spencer
Journal of Immunotherapy With Emphasis on Tumor Immunology. 1994-01-01 - 29 citationsA pilot study of the combination of interleukin-2-based immunotherapy and radiation therapyJ. R. Lange, A. A. Raubitschek, Barbara A. Pockaj, William F. Spencer, Michael T. Lotze
Journal of Immunotherapy. 1992-11-01 - 49 citationsImmunotherapy with Interleukin-2 and α-Interferon in Patients with Metastatic Renal Cell Cancer with in Situ Primary Cancers: A Pilot StudyWilliam F. Spencer, W. Marston Linehan, McClellan M. Walther, Gabriel P. Haas, Michael T. Lotze
The Journal of Urology. 1992-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
